1 / 5

The NIH Common Fund

The NIH Common Fund. James Anderson, M.D., Ph.D. Director Division of Program Coordination, Planning, and Strategic Initiatives October 27, 2011. Common Fund Programs FY2011. HRHR. Epigenomics. HMP. CTSAs.

albina
Download Presentation

The NIH Common Fund

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The NIH Common Fund James Anderson, M.D., Ph.D.Director Division of Program Coordination, Planning, and Strategic Initiatives October 27, 2011

  2. Common Fund Programs FY2011 HRHR Epigenomics HMP CTSAs Molecular Libraries IR

  3. Common Fund programs catalyze research across a broad spectrum of diseases/conditions • ■Enabling Infrastructure • ■Rapid Access to Intervention Development (RAID) • ■Molecular Libraries and Imaging • ■ New Tools, Technologies, Data • ■ Library of Integrated Networks of Cellular Signatures (LINCS) • ■Human Microbiome Project

  4. LINCS is providing comprehensive data on the global response of signaling networks to perturbagens. Data generation, analysis, integration Cell types Functional annotation with existing knowledge Phenotypic assays Perturbagens

  5. Questions for LINCS to consider in planning for its second phase: 1. Is the program truly transforming – could it dramatically affect how biomedical research is conducted within a predictable timeframe? 2. Can the transformative outcome be accomplished or milestones reached within the 5-10 yr period of funding from the Common Fund? 3. Will the outcomes synergistically promote and advance the individual missions of NIH ICs to promote health? CF programs should enable, strengthen, and promote IC-funded research. 4. Is the program sufficiently complex that it requires coordination of the efforts of multiple ICs? Is the initiative not easily assignable to the mission of a single IC? 5. Is the proposed initiative something that no other entity is likely or able to do? If other entities are also engaged, what is the gap that the CF will fill? How will related activities be coordinated?

More Related